Agenus, Inc. (AGEN)
4.085
+0.16
(+4.21%)
USD |
NASDAQ |
Dec 10, 16:00
4.085
0.00 (0.00%)
After-Hours: 16:21
Agenus Total Assets (Quarterly): 233.89M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 69.39M |
| Armata Pharmaceuticals, Inc. | 89.52M |
| Bionano Genomics, Inc. | 79.06M |
| Twist Bioscience Corp. | 641.86M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 514.76M |
| Shareholders Equity (Quarterly) | -274.14M |
| Debt to Equity Ratio | -1.244 |
| Current Ratio | 0.4665 |
| Net Debt Paydown Yield | 11.18% |